Other denominations
Principal investigator
Description
The Law on Medicinal Products defines clinical trials as "all experimental evaluation of a substance or drug through its administration or application to human beings". The process for the approval of a new medication for human use is complex and time consuming. After pre-clinical investigation (in vitro and in animals), a new drug is tested on humans during clinical trials (phase II, phase III and phase IV, depending on the type of population and number of patients included). The whole process usually involves at least 3,000 people, lasts between five and ten years, and can have a total cost of between 300 and 500 million euros. Registration requires presenting all the scientific documentation of consecutive protocols and the results obtained.
The clinical trial coordinator is the person responsible for the clinical trials of a (bio) pharmaceutical company or CRO (Contract Research Organization). In general, this professional directs a team of several specialists in different fields (assistants, clinical trial monitors, biostatisticians and computer engineers). This requires close collaboration with authorities, physicians/specialists or opinion leaders, and internal R&D departments.
Tasks
© Barcelona Activa 2023
Centre per al desenvolupament professional Porta22
Barcelona Treball (Porta22)
Llacuna, 156-162, 08018 Barcelona
bcn.cat/treball
Monday to Friday from 9 to 18 h